Preliminary data indicate the rate of sepsis mortality related to overall patient deaths is dropping at University Health Care System in Augusta, Ga. So what are they doing differently? Accelerate ...

TUCSON, Ariz., March 21, 2025 /PRNewswire/ — Accelerate Diagnostics, Inc. (Nasdaq: AXDX), an innovator in rapid in vitro diagnostics for microbiology, today announced the submission of its Accelerate ...

TUCSON, Ariz., Nov. 27, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX) an innovator of rapid in vitro diagnostics in microbiology, announced the signing of a collaboration and quality ...

TUCSON, Ariz., Sept. 30, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX), an innovator of rapid in vitro diagnostics, announced that the U.S. Food and Drug Administration (FDA) has granted ...

Continued to execute contract extensions with strategic customers with greater than 75% of U.S. Pheno customers secured through the anticipated WAVE commercial launch, subject to regulatory approvals.

TUCSON, Ariz., March 7, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Thursday, March 28, 2024, at 4:30 p.m. Eastern ...

Shares of Accelerate Diagnostics Inc AXDX, an in-vitro diagnostics company, spiked higher by more than 15 percent early Friday morning after the company provided an update relating to its Accelerate ...

The Accelerate WAVE system is designed to provide rapid antimicrobial susceptibility testing (AST) directly from positive blood culture bottles and bacterial isolate colonies. The WAVE system is ...

Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. In addition to the Accelerate Arc system ...